Director of Care Pathway Strategy & Acceleration

Ipsen Biopharmaceuticals Inc.; United States; On-site; USD 218,000 - 315,000; Full time

Job summary

Ipsen Biopharmaceuticals Inc. is seeking a Senior Director, Head of Care Pathway Optimization to establish and lead a new strategic capability in the United States, accelerating diagnosis and optimizing care pathways for the rare disease portfolio.

The role defines vision, operating model, and success metrics, partnering with healthcare systems to improve the patient journey from identification to treatment initiation.

Qualifications

• Minimum 15+ years of Pharma/Biotech/Medical Devices with extensive industry experience in health systems.
• Minimum 5+ years of prior experience leading teams critical demonstrated experience driving care pathway optimization, patient journey initiatives, and institutional engagement strategies.
• Deep understanding of health system operations, care delivery models, provider economics, and organized customer strategy.
• Deep understanding of healthcare data (claims, SP/SD. etc.)
• Expertise in developing and executing strategic partnerships with IDNs/ provider groups.
• Demonstrated ability to work cross functionally and effectively anticipate customer needs.
• Specialty therapeutics experience preferred.

Responsibilities

• Establish and lead the enterprise strategy for diagnosis acceleration and care pathway optimization across the U.S. portfolio.
• Define the vision, operating model, priorities, and success measures for Ipsen's Care Pathway Optimization function.
• Create and lead Ipsen's Care Pathway Optimization function, establishing the team structure, attracting and developing top talent, and building a scalable organization positioned to meet evolving business needs and support long‑term portfolio growth.
• Identify barriers throughout the patient journey, including diagnosis, referral & treatment initiation, to develop solutions to address them.
• Partner with data team to leverage analytics, real-world evidence, health system data, and customer insights to inform strategic decisions and care pathway initiatives.
• Develop and lead the team responsible for engaging with key external stakeholders at institutions to identify and execute partnership opportunities to improve patient care pathways by developing solutions that support improved diagnosis.
• Lead the development and execution of innovative programs that accelerate diagnosis and optimize care pathways for patients with rare diseases.
• Serve as Ipsen's senior commercial leader and subject matter expert on health system engagement, care delivery transformation, and patient journey optimization.
• Drive cross‑functional alignment across Commercial, Marketing, Value & Access, Business Operations, Medical Affairs, Patient Services, Legal, and Business Ethics to shape and execute enterprise strategies that accelerate diagnosis and improve patient care pathways.
• Ensure care pathway strategies are incorporated into portfolio planning, launch readiness, and long‑term commercial strategy.
• Influence organizational priorities and investment decisions through data‑driven recommendations, business cases, and executive communications.
• Foster an enterprise mindset through effective resource allocation, budget stewardship, and continuous improvement of organizational capabilities.
• Ensure all initiatives are executed in accordance with legal, regulatory, compliance, and business ethics requirements.

Skills

Health systems engagement

Strategic partnerships

Cross-functional leadership

Patient journey analytics

Education

Bachelor’s Degree

Advanced Degree preferred

Job description

Ipsen Biopharmaceuticals Inc. is seeking a Senior Director, Head of Care Pathway Optimization to establish and lead a new strategic capability in the United States, accelerating diagnosis and optimizing care pathways for the rare disease portfolio.

The role defines vision, operating model, and success metrics, partnering with healthcare systems to improve the patient journey from identification to treatment initiation.